Evidence map›Paper›PMID 24303070›Full record

ArticlePloS one2013

WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation.

Sandrine L Anne, Eve-Ellen Govek, Olivier Ayrault, Jee Hae Kim, Xiaodong Zhu, David A Murphy, Linda Van Aelst, Martine F Roussel, Mary E Hatten

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 80 citations in OpenAlex.

  1. Autoencoder Denoising for Network-Based Spatial Transcriptomics Data with Applications for Cell Signaling Estimation.Complex networks & their applications. International Conference on Complex Networks and Their Applications · 2026
    Article
  2. Article
  3. Cell signaling characterization for spatial transcriptomics (ST) data using network analysis.Complex networks & their applications. International Conference on Complex Networks and Their Applications · 2025
    Article
  4. Article
  5. Article
  6. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sandrine L AnneLaboratory of Developmental Neurobiology, The Rockefeller University, New York, New York, United States of America.
Eve-Ellen Govek
Olivier Ayrault
Jee Hae Kim
Xiaodong Zhu
David A Murphy
Linda Van Aelst
Martine F Roussel
Mary E Hatten
Rockefeller University · USSt. Jude Children's Research Hospital · USCold Spring Harbor Laboratory · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
DOCK7 Signaling in Neuronal DevelopmentR01MH082808 · NIMH · COLD SPRING HARBOR LABORATORY · PI VAN AELST, LINDA · 2008 to 2017
$4.7M
Role of mPar6 Polarity in CNS Neuronal MigrationR01NS051778 · NINDS · ROCKEFELLER UNIVERSITY · PI HATTEN, MARY ELIZABETH · 2006 to 2015
$3.7M
The Anaphase Promoting Complex and Cell Cycle ExitR01NS067289 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AYAD, NAGI G · 2010 to 2014
$2.3M
NCI NIH HHS CA-021765NCI NIH HHS CA-096832NCI NIH HHS P01 CA096832NCI NIH HHS P30 CA021765NIMH NIH HHS MH082808NIMH NIH HHS R01 MH082808NINDS NIH HHS NS-051778NINDS NIH HHS NS-067289NINDS NIH HHS R01 NS051778NINDS NIH HHS R01 NS067289
6 · The paper itself

Abstract

During normal cerebellar development, the remarkable expansion of granule cell progenitors (GCPs) generates a population of granule neurons that outnumbers the total neuronal population of the cerebral cortex, and provides a model for identifying signaling pathways that may be defective in medulloblastoma. While many studies focus on identifying pathways that promote growth of GCPs, a critical unanswered question concerns the identification of signaling pathways that block mitogenic stimulation and induce early steps in differentiation. Here we identify WNT3 as a novel suppressor of GCP proliferation during cerebellar development and an inhibitor of medulloblastoma growth in mice. WNT3, produced in early postnatal cerebellum, inhibits GCP proliferation by down-regulating pro-proliferative target genes of the mitogen Sonic Hedgehog (SHH) and the bHLH transcription factor Atoh1. WNT3 suppresses GCP growth through a non-canonical Wnt signaling pathway, activating prototypic mitogen-activated protein kinases (MAPKs), the Ras-dependent extracellular-signal-regulated kinases 1/2 (ERK1/2) and ERK5, instead of the classical β-catenin pathway. Inhibition of MAPK activity using a MAPK kinase (MEK) inhibitor reversed the inhibitory effect of WNT3 on GCP proliferation. Importantly, WNT3 inhibits proliferation of medulloblastoma tumor growth in mouse models by a similar mechanism. Thus, the present study suggests a novel role for WNT3 as a regulator of neurogenesis and repressor of neural tumors.

Indexed as

AnimalsBone Morphogenetic ProteinsCell DifferentiationCell Line, TumorCell ProliferationCell Transformation, NeoplasticCerebellar NeoplasmsDisease Models, AnimalEnzyme ActivationGene ExpressionMAP Kinase Signaling SystemMedulloblastomaMiceMice, KnockoutMitogen-Activated Protein KinasesNeural Stem CellsBone Morphogenetic ProteinsMitogen-Activated Protein KinasesWnt3 Protein

Identifiers

PMID24303070
PMCPMC3841149
OpenAlexW2000822014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.